Fluorodeoxyglucose Imaging Studies to Detect Lymphoma
Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) to Evaluate Autoimmune Lymphoproliferative Syndrome (ALPS) and ALPS-associated Lymphoma
Pyrimethamine to Treat Autoimmune Lymphoproliferative Syndrome
Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death
† Study has passed its completion date and status has not been verified in more than two years.